Magnetar Financial LLC Zymeworks Inc. Transaction History

Magnetar Financial LLC

  • $3.44 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019
SELL
$14.02 - $16.74 $210,300 - $251,099
-15,000 Closed
0 $0
Q4 2018

Feb 14, 2019
SELL
$10.95 - $15.44 $110,102 - $155,249
-10,055 Reduced 40.13%
15,000 $220,000
Q3 2018

Nov 14, 2018
BUY
$12.21 - $16.61 $671 - $913
55 Added 0.22%
25,055 $393,000
Q2 2018

Aug 14, 2018
BUY
$11.13 - $21.86 $278,250 - $546,500
25,000 New
25,000 $370,000

Others Institutions Holding ZYME

# of Institutions
1
Shares Held
296K
Call Options Held
0
Put Options Held
0
View Full List

About Zymeworks Inc.

ZYME Quotes by TradingView
  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $882M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Magnetar Financial LLC Portfolio

Follow Magnetar Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnetar Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email